TYK Medicines (HKSE:02410) Treasury Stock: HK$-21.39 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02410 TYK Medicines Inc HKSE:02410
7 GF Score
Price HK$3.07
! 3 Warning Signs
View Full Analysis

What is TYK Medicines Treasury Stock?

TYK Medicines HKSE:02410 +2.85% 7 Treasury Stock is HK$-21.39 Mil as of Jun. 2026. GuruFocus rates HKSE:02410 with a GF Score™ of 7/100. The stock has 3 warning signs investors should review.

Treasury stock is the portion of shares that a company keeps in their own treasury. TYK Medicines's treasury stock for the quarter that ended in Jun. 2026 was HK$-21.39 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

TYK Medicines Treasury Stock Historical Data

* Premium members only.

The historical data trend for TYK Medicines's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TYK Medicines Treasury Stock Chart

TYK Medicines Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Treasury Stock
0.00 0.00 0.00 -19.52

TYK Medicines Quarterly Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Treasury Stock Get a 7-Day Free Trial 0.00 0.00 0.00 -19.52 -21.39
HKSE:02410
7GF Score
TYK Medicines Inc HKSE:02410
Treasury Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TYK Medicines Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Frequently Asked Questions Learn more about Treasury Stock →
What does a Treasury Stock of HK$-21.39 Mil mean?
TYK Medicines (HKSE:02410) has a Treasury Stock of HK$-21.39 Mil as of Jun. 2026. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for TYK Medicines and its competitors.
Is TYK Medicines' Treasury Stock too high?
TYK Medicines' current Treasury Stock is HK$-21.39 Mil. Overall, TYK Medicines has a GF Score™ of 7/100, reflecting its overall financial health beyond just this single metric.
How does TYK Medicines' Treasury Stock compare to VRTX and REGN?
TYK Medicines' Treasury Stock of HK$-21.39 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Treasury Stock for a Biotechnology company?
A good Treasury Stock depends on the Biotechnology industry context. However, Treasury Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Treasury Stock mean?
A high Treasury Stock can signal that a stock is expensive relative to its fundamentals. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for TYK Medicines and its competitors. TYK Medicines's current Treasury Stock is HK$-21.39 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TYK Medicines stock overvalued right now?
TYK Medicines (HKSE:02410) has a current Treasury Stock of HK$-21.39 Mil. The current Treasury Stock is HK$-21.39 Mil. TYK Medicines' overall GF Score™ is 7/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Treasury Stock calculated?
Treasury Stock is calculated from a company's financial statements. For TYK Medicines (HKSE:02410), the current Treasury Stock is HK$-21.39 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TYK Medicines Business Description

Address No.277 Longlan Road, 8th Floor, Building T2, China Eastern Binjiang Center, Xuhui District, Shanghai, CHN
TYK Medicines Inc is a clinical-stage biopharmaceutical company. The company is engaged in drug discovery research and development. The company and its subsidiaries are principally engaged in the research, development, and commercialization of pharmaceutical products. The company has built a pipeline with10 drug candidates, including Core Product TY-9591, five clinical stage products, and four preclinical stage or early clinical development stage.
7GF Score

Get the complete analysis for HKSE:02410

Treasury Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$3.07
Price